Factor VIIa-(poly)sialic acid conjugate having prolonged in vivo half-life

Details for Australian Patent Application No. 2007333049 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Turecek, Peter; Siekmann, Juergen; Canavaggio, Michel; Scheiflinger, Friedrich

Agent Cullen & Co

Pub. Number AU-A-2007333049

PCT Pub. Number WO2008/074032

Priority 60/875,217 15.12.06 US

Filing date 14 December 2007

Wipo publication date 19 June 2008

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/074032 Priority application(s): WO2008/074032

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333050-Compositions and methods of using (R)-pramipexole

2007333048-Compositions and methods for treating infectious bronchitis